DermaSensor’s Cody Simmons Named to Forbes “30 Under 30” List

DermaSensor’s Cody Simmons Named to Forbes “30 Under 30” List

DermaSensor’s Cody Simmons Named to Forbes “30 Under 30” List
Simmons Recognized for Leadership of Miami-based Skin Cancer Startup

Miami, Fla. – November 15, 2017 – Forbes today announced its 2018 “30 Under 30” list of young leaders disrupting industry. Cody Simmons, Chief Executive Officer of the Miami-based digital health company DermaSensor, was selected from over 15,000 nominations around the country for his leadership in healthcare.

DermaSensor is developing clinical decision support tools to increase the accuracy of skin lesion triage, decrease unnecessary referrals to dermatologists, and improve access to skin cancer screening. Under Simmons’ leadership, DermaSensor has obtained three issued patents, completed a two-year clinical trial with two additional clinical validation studies underway, won the consumer-facing solution at Health 2.0’s pitch competition, and raised $4.5 million in seed funding. Simmons previously led commercial and business development efforts at DigiSight Technologies, a Silicon Valley connected device startup, and prior to that spent several years at Genentech, a prominent biotechnology company.

“At DermaSensor, we are building an innovative product that has the potential to transform skin health – increasing access to care by delivering a low-cost and high-quality tool,” stated Simmons. “It was an honor to just be considered for the Forbes ’30 Under 30’ list. Being selected amongst this list of leaders is inspirational and validates our team’s hard work.”

Previous “30 Under 30” honorees include industry pioneers such as Facebook’s Mark Zuckerberg, Snapchat’s Evan Spiegel, Hollywood actress Jennifer Lawrence, and Pulitzer Prize winning journalist Wesley Lowery. This year, 50% of the leaders that made it on the list were founders or cofounders.

 

About the Company:

DermaSensor, a Miami-based digital health company, is a connected device company that enables healthcare professionals to efficiently check for skin cancer by leveraging cutting-edge technologies. DermaSensor has developed an affordable handheld tool that uses artificial intelligence and spectroscopy to evaluate skin lesions for potential skin cancer in a matter of seconds. By enabling quick and effective skin cancer checks, DermaSensor hopes to ultimately improve patient outcomes. To learn more, visit www.dermasensor.com.

 

Media Contact
Palak Bhatnagar
contact@dermasensor.com
415-322-0838